Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT03080311 2022-07-12

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

Phase 1 Completed

50 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT03387332 2021-08-27

APG-1252 in Patients With SCLC or Advanced Solid Tumors

Phase 1 Terminated

24 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Phase 1 Completed

89 enrolled

BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

SKB500 Combinations in Patients With Small Cell Lung Cancer

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

KEYNOTE F19

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

APG-1252 in Patients With SCLC or Advanced Solid Tumors

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies